Summary
Eli Lilly and Company (LLY) filed an 8-K on February 6, 2019, primarily to furnish a press release detailing their fourth quarter and full fiscal year 2018 financial results. While the 8-K itself is brief, it directs investors to the attached Exhibit 99.1, which contains the substantive financial and operational information. This filing serves as the official announcement of the company's performance for the period ending December 31, 2018, including unaudited operating results. Investors should carefully review the press release (Exhibit 99.1) for comprehensive details on Lilly's financial condition and results of operations. This includes information on revenue, profitability, and potentially key product performance metrics. The filing also indicates that non-GAAP financial results and 2019 guidance are included in the press release, along with reconciliations, which are important for understanding the company's outlook and performance beyond standard accounting measures.
Key Highlights
- 18-K filing on February 6, 2019, announces fourth quarter and full fiscal year 2018 results.
- 2Press release (Exhibit 99.1) contains unaudited operating results for the reported periods.
- 3The filing incorporates by reference the press release for detailed financial and operational information.
- 4Non-GAAP financial results for the reported periods are presented in the press release.
- 5Company's non-GAAP guidance for fiscal year 2019 is also included in the press release.
- 6Reconciliations between GAAP and non-GAAP financial measures are provided in Exhibit 99.1.